Q2 EPS Estimate for Rein Therapeutics Raised by Analyst
Rein Therapeutics, Inc. (NASDAQ:RNTX – Free Report) – Brookline Capital Management increased their Q2 2025 earnings per share estimates for Rein Therapeutics in a research note issued on Tuesday, April 22nd. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of ($0.22) for the quarter, up from their […]
Rein Therapeutics, Inc. (NASDAQ:RNTX – Free Report) – Brookline Capital Management increased their Q2 2025 earnings per share estimates for Rein Therapeutics in a research note issued on Tuesday, April 22nd. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of ($0.22) for the quarter, up from their […]
